Introduction
Telmivas M is a prescription medication that combines two active ingredients: Telmisartan and Metoprolol Succinate. Telmisartan is a type of medication called an angiotensin receptor blocker (ARB), and Metoprolol Succinate is a beta-blocker. This combination of medications is used to treat high blood pressure (hypertension) in adults.
Uses
Telmivas M is primarily prescribed for the management of high blood pressure. It helps to lower blood pressure by relaxing and widening the blood vessels, allowing the blood to flow more easily. This can help to reduce the risk of heart attacks, strokes, and other complications associated with high blood pressure.
Dosage and Administration
follow the dosage instructions provided by your healthcare professional. The usual starting dose of Telmivas M is one tablet per day. Your doctor may adjust the dose based on your individual response to the medication. The tablets should be swallowed whole with a glass of water, preferably at the same time each day. It is important not to crush or chew the tablets.
Mechanism of Action
Telmisartan works by blocking the action of a hormone called angiotensin II, which constricts the blood vessels and increases blood pressure. By blocking the effects of angiotensin II, Telmisartan helps to relax and widen the blood vessels, reducing blood pressure. Metoprolol Succinate, on the other hand, works by blocking the effects of adrenaline and reducing the heart rate, thus further lowering blood pressure.
Side Effects
Common side effects may include dizziness, fatigue, headache, and low blood pressure. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as difficulty breathing, chest pain, or swelling of the face, lips, or tongue, seek immediate medical attention.
Drug Interactions
Telmivas M may interact with other medications, including certain antidepressants, antidiabetic medications, and nonsteroidal anti-inflammatory drugs (NSAIDs). Inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products, to avoid potential drug interactions.
Precautions
Before taking Telmivas M, inform your healthcare professional about any pre-existing medical conditions you may have, including liver or kidney problems, heart disease, asthma, or diabetes. This medication may not be suitable for everyone, and your doctor will assess whether it is appropriate for you. Telmivas M should be used with caution in patients with certain conditions, such as heart block or severe heart failure.
Storage
Telmivas M should be stored at room temperature, away from moisture and heat. Keep the medication out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.
Patient Tips
- Take Telmivas M exactly as prescribed by your healthcare professional.
- It may take some time for the medication to start working. Be patient and continue taking it as directed.
- Do not stop taking Telmivas M without consulting your doctor, as sudden discontinuation may cause a rapid increase in blood pressure.
- If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
- Follow a healthy lifestyle, including a balanced diet, regular exercise, and stress management, to complement the effects of the medication in managing your blood pressure.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Metoprolol: medicine for high blood pressure (hypertension) (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
- Micardis 40 mg tablets (Health Professionals SmPC) Available at:
- Metoprolol (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
- telmisartan (micardis) (RX) [Accessed 27 Jun. 2024] (online) Available at:
- High Blood Pressure (Food and Drug Administration) [Accessed 13 Jun. 2024] (online) Available at:
- Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol. 2017 Sep;106(9):711-721. doi: 10.1007/s00392-017-1115-0. Epub 2017 Apr 22. [Accessed 2 Jun. 2024] Available at:
Reviews
There are no reviews yet.